A Meta-Analysis of Retention in Methadone Maintenance by Dose and Dosing Strategy

REFERENCES

• Dole V P, Nyswander M E, Kreek M J. Narcotic blockade. Arch Intern Med 1966; 118(4)304–309
   PubMed Web of Science ®Google Scholar
• Strain E C, Bigelow G E, Liebson I A, Stitzer M L. Moderate- vs. High-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999; 281(11)1000–1005
   PubMed Web of Science ®Google Scholar
• Dole V P, Robinson J W, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med 1969; 19: 1372–1375
   Web of Science ®Google Scholar
• Dole V P, Nyswander M E. A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride. JAMA 1965; 193(8)80–84
   Web of Science ®Google Scholar
• Metzger D S, Woody G E, McLellan A T, O'Brien C P, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993; 6(9)1049–1056
   PubMed Web of Science ®Google Scholar
• Thiede H, Hagan H, Murrill C S. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health 2000; 77(3)331–345
   PubMed Web of Science ®Google Scholar
• NIH Consensus Conference. Effective medical treatment of opiate addiction. JAMA 1998; 280(22)1936–1943
   PubMed Web of Science ®Google Scholar
• Department of Health. Drug Misuse and Dependence—Guidelines on Clinical Management. Department of Health, London 1999
   Google Scholar
• Luo W, Pan L, Wu Z Y, Mi G D, Wang C H, Li J H. Enrollment and retention rate of patients in the first batch of methadone maintenance clinics in China. Chinese Mental Health Journal 2007; 121(7)478–480
   Google Scholar
• Newman R G, Whitehill W B. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet. 1979; 2(8141)485–488
   PubMed Web of Science ®Google Scholar
• Ball J C, Corty E. Basic issues pertaining to the effectiveness of methadone maintenance treatment. NIDA Res Monogr. 1988; 86: 178–191
   PubMedGoogle Scholar
• Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for oipoid dependence. Cochrane Database of Systematic Reviews 2003, (3):CD002208, doi:10.1002 /14651858
   PubMedGoogle Scholar
• Farre M, Mas A, Torrens M, Moreno V, Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug Alcohol Depend 2002; 65(3)283–290
   PubMed Web of Science ®Google Scholar
• Amato L, Davoli M A, Perucci C, Ferri M, Faggiano F P, Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005; 28(4)321–329
   PubMed Web of Science ®Google Scholar
• Gruber V A, Delucchi K L, Kielstein A, Batki S L. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend 2008; 94(1–3)199–206
   PubMed Web of Science ®Google Scholar
• Leavitt S B, Shinderman M, Maxwell S, Eap C B, Paris P. When “enough” is not enough: new perspectives on optimal methadone maintenance dose. Mt Sinai J Med 2000; 67(5–6)404–411
   PubMedGoogle Scholar
• Trafton J A, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Med 2006; 3(3)1549–1676
   Web of Science ®Google Scholar
• Johnson R E, Chutuape M A, Strain E C, Walsh S L, Stitzer M L, Bigelow G E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343(18)1290–1297
   PubMed Web of Science ®Google Scholar
• Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor R J, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor R S. Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technol Assess. 2007; 11(9)1–171
   PubMed Web of Science ®Google Scholar
• Johnson R E, Jaffe J H, Fudala P J. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267(20)2750–2755
   PubMed Web of Science ®Google Scholar
• Goldstein A, Judson B A. Efficacy and side effects of three widely different methadone doses. Proc Natl Conf Methadone Treat 1973; 1: 21–44
   PubMedGoogle Scholar
• Preston K L, Umbricht A, Epstein D H. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch Gen Psychiatry 2000; 57(4)395–404
   PubMed Web of Science ®Google Scholar
• Ling W, Wesson D R, Charuvastra C, Klett C J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 1996; 53(5)401–407
   PubMed Web of Science ®Google Scholar
• Ling W, Charuvastra C, Kaim S C, Klett C J. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study. Arch Gen Psychiatry 1976; 33(6)709–720
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, Bigelow G E. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 1993; 119(1)23–27
   PubMed Web of Science ®Google Scholar
• Kosten T R, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993; 181(6)358–364
   PubMed Web of Science ®Google Scholar
• Panell J, Charuvastra V C, Ouren J. Methadyl acetate versus methadone: The experience of one hospital. Med J Aust 1977; 2(5)150–152
   PubMed Web of Science ®Google Scholar
• Schottenfeld R S, Pakes J R, Oliveto A, Ziedonis D, Kosten T R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 1997; 54(8)713–720
   PubMed Web of Science ®Google Scholar
• Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stuhlinger G, et al. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999; 94(9)1337–1347
   PubMed Web of Science ®Google Scholar
• Jaffe J H, Senay E C, Schuster C R, Renault P R, Smith B, DiMenza S. Methadyl acetate vs methadone. A double-blind study in heroin users. JAMA 1972; 222(4)437–442
   PubMed Web of Science ®Google Scholar
• Mattick R P, Ali R, White J M, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 98(4)441
   PubMed Web of Science ®Google Scholar
• Pani P P, Maremmani I, Pirastu R, Tagliamonte A, Gessa G L. Buprenorphine: A controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend 2000; 60(1)39–50
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, Bigelow G E. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology (Berl) 1994; 116(4)401–406
   PubMed Web of Science ®Google Scholar
• Strain E C, Stitzer M L, Liebson I A, Bigelow G E. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatr 1994; 151(7)1025–1030
   PubMed Web of Science ®Google Scholar
• Caplehorn J R, Dalton M S, Cluff M C, Petrenas A M. Retention in methadone maintenance and heroin addicts'risk of death. Addiction 1994; 89(2)203–209
   PubMed Web of Science ®Google Scholar
• D'Ippoliti D, Davoli M, Perucci C A, Pasqualini F, Bargagli A M. Retention in treatment of heroin users in Italy: the role of type and of methadone maintenance dosage. Drug Alcohol Depend 1998; 52(2)167–171
   PubMed Web of Science ®Google Scholar
• Ehret G B, Desmeules J A, Broers B. Methadone-associated long QT syndrome: Improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opinion on Drug Safety 2007; 6(3)289–303
   PubMed Web of Science ®Google Scholar
• Thomas D, Harold A P. Changes in methadone treatment practices results from a national panel study, 1988–2000. JAMA 2002; 288(7)850–856
   PubMed Web of Science ®Google Scholar
• Del Rio M, Mino A, Perneger T V. Predictors of patient retention a newly established methadone maintenance treatment programme. Addiction 1997; 92(10)1353–1360
   PubMed Web of Science ®Google Scholar
• Booth R E, Corsi K F, Mikulich Gilbertson S K. Factors associated with methadone maintenance treatment retention among street recruited injection drug users. Drug Alcohol Depend 2004; 74(2)177–185
   PubMed Web of Science ®Google Scholar
• Blaney T, Craig R J. Methadone maintenance: Does dose determine differences in outcome?. J Subst Abuse Treat 1999; 16(3)221–228
   PubMed Web of Science ®Google Scholar
• Schmitz J M, Rhoades H M, Elk R, Creson D, Hussein I, Grabowski J. Medication take-home doses and contingency management. Exp Clin Psychopharmacol 1998; 6(2)162–168
   PubMed Web of Science ®Google Scholar